Stockreport

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF [Yahoo! Finance]

Tectonic Therapeutic, Inc.  (TECX) 
PDF Tectonic Therapeutic Thu, January 30, 2025 at 12:30 PM GMT+1 11 min read In This Article TECX Tectonic Therapeutic TX45 improved both left ventricular funct [Read more]